EUDA Health Holdings Ltd (EUDA) Cash & Equivalents (2021 - 2025)

EUDA Health Holdings (EUDA) has reported Cash & Equivalents for 5 consecutive years, with $345145.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash & Equivalents rose 45.26% year-over-year to $345145.0; the TTM figure through Dec 2025 stood at $345145.0 (up 45.26% YoY), while the FY2025 annual figure was $345145.0, up 45.26% from the prior year.
• Cash & Equivalents advanced to $345145.0 in Q4 2025 per EUDA's latest filing, from $176584.0 in the prior quarter.
• Across five years, Cash & Equivalents topped out at $837292.0 in Q1 2023 and bottomed at $176584.0 in Q2 2025.
• Historically, Cash & Equivalents has averaged $374557.7 across 5 years, with a median of $293169.0 in 2022.
• Annual changes were most pronounced in 2022 — Cash & Equivalents surged 312.9% — and 2023, when it plunged 74.82%.
• EUDA Health Holdings' Cash & Equivalents stood at $189996.0 in 2021, then soared by 312.9% to $784485.0 in 2022, then slumped by 74.82% to $197554.0 in 2023, then increased by 20.27% to $237605.0 in 2024, then jumped by 45.26% to $345145.0 in 2025.
• Business Quant data shows EUDA's Cash & Equivalents at $345145.0 in Q4 2025, $176584.0 in Q2 2025, and $237605.0 in Q4 2024.